Purpose: To evaluate the microstructure of the inner and outer retina and the visual function after macular hole (MH) surgery using brilliant blue G (BBG) or indocyanine green (ICG) to make the internal limiting membrane (ILM) more visible.

Design: Comparative, retrospective, interventional case series.

Participants: Sixty-three eyes of 63 consecutive cases with MH were studied. Thirty-five eyes of 35 cases were treated with BBG between January and August 2011. Twenty-eight eyes of 28 MH cases were treated with ICG from April 2009 through April 2010.

Methods: Vitrectomy was performed with a 23-gauge system and 0.25 mg/ml BBG or with 0.125% ICG.

Main Outcome Measures: The best-corrected visual acuity (BCVA) and the microperimetry-determined retinal sensitivity were measured at baseline and at 3 and 6 months after surgery. The length of the defect of the photoreceptor inner segment/outer segment (IS/OS) junction and external limiting membrane (ELM), the central foveal thickness (CFT), and the thickness of the ganglion cell complex (GCC) were measured in the spectral-domain optical coherence tomographic images.

Results: The average BCVA was significantly better in the BBG group than in the ICG group at 3 months (P = 0.021) and 6 months (P = 0.045) after surgery. The mean retinal sensitivity in the BBG group was improved significantly in the central 2° at 3 and 6 months (P = 0.001 and P = 0.030, respectively), but was not significantly improved in the adjacent 10°. The length of IS/OS junction defect was significantly shorter in the BBG group at 3 months (P = 0.048), but was not significantly different at 6 months (P = 0.135). The length of ELM defect and the GCC thickness were not significantly different between the 2 groups at 3 and 6 months. The CFT was significantly thinner in the ICG group than in the BBG group at 3 and 6 months (P = 0.013 and P = 0.001, respectively).

Conclusions: The postoperative BCVA and retinal sensitivity in the central 2° were better in eyes after BBG-assisted vitrectomy. The restoration of IS/OS junction was faster in the BBG group, and the CFT was significantly thinner in eyes after ICG. Brilliant blue G may be a better agent than ICG to make the ILM more visible.

Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2012.06.048DOI Listing

Publication Analysis

Top Keywords

bbg group
20
brilliant blue
12
retinal sensitivity
12
is/os junction
12
group months
12
indocyanine green
8
macular hole
8
bbg
8
limiting membrane
8
eyes cases
8

Similar Publications

Colorectal Cancer Screening and Social Needs.

J Am Board Fam Med

January 2025

From the Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA (IRF, EEH, CAS); Kaiser Permanente Bernard J. Tyson School of Medicine, Office of Research and Scholarship, Pasadena, CA (RG, MCD); Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science, Pasadena, CA (BBG, RSN, QNM); Kaiser Permanente Washington Health Research Institute, Seattle, WA (BBN); Center for Health Research, Kaiser Permanente Northwest, Portland, OR (GDC); Department of Research and Evaluation, Kaiser Permanente Southern California, Los Angeles, CA (EEH); Hawaii Permanente Medical Group, Honolulu, HI (SAH); The Southeast Permanente Medical Group, Atlanta, GA (KK); Kaiser Permanente Division of Research, Oakland, CA (TRL); Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO (CAS).

Introduction: Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. While patient-reported barriers have been previously described, few studies have analyzed how patients' social needs affect screening rates.

Methods: This cross-sectional study includes 3,443 Kaiser Permanente (KP) patients ages 50 to 75 years who completed the 2020 KP National Social Needs Survey.

View Article and Find Full Text PDF

Objective: This study aimed to compare the accuracy of brain biopsies in skull-brain tumor models (SBTMs) of dogs and cats using 2 techniques: 3-D-printed brain biopsy guides (3D-BBGs) and electromagnetic (EM) neuronavigation.

Methods: Based on the CT data from 12 dogs and 3 cats, a total of 30 SBTMs were created using 3-D-printing technology, with 2 models per data set. Thirty brain biopsies were performed: 15 using 3D-BBGs and 15 using EM neuronavigation.

View Article and Find Full Text PDF

Purpose: To investigate the mechanism underlying the effects of Tongdu Tiaoshen electroacupuncture in the treatment of cerebral ischemia-reperfusion (I/R) injury.

Methods: Sixty adult male Sprague-Dawley (SD) rats were randomly allocated to five groups (n=12): Sham, I/R, electroacupuncture (EA), BBG (P2X7R inhibitor), and MCC950 (NLRP3 inhibitor). The EA group received acupuncture at Shenting (GV24), Baihui (GV20), and Dazhui (GV14) points with a stimulation frequency of 2/5 Hz, intensity of 2 mA, and a duration of 40 min.

View Article and Find Full Text PDF

The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury.

Purinergic Signal

November 2024

Laboratory of Immunophysiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Purinergic signaling plays a role in the pathophysiology of different viral infections. Recently, we showed that COVID-19 increases extracellular ATP levels, which may amplify the pro-inflammatory signals in the disease. The P2X7 receptor can be a protagonist in the pro-inflammatory responses.

View Article and Find Full Text PDF

P2X7 is a purinergic receptor physiologically activated by extracellular ATP. Its activation induces proinflammatory responses, including cytokine release, reactive oxygen species formation, and cell death. Previous in vivo experimental models demonstrated that P2X7 blockade has anti-inflammatory effects; however, there are no drugs used in clinical therapy that act on the P2X7 receptor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!